Bill Ackman’s Got A Fever And The Only Prescription Is More Takeovers

Ackman, who has teamed up with Canadian pharmaceutical company Valeant to launch a $45.6 billion takeover of Botox maker Allergan, warned drugmakers Tuesday that he plans to go on a little buying spree. “This is not the last deal we’re going to do,” he said. “We’re already talking about the next deal we’re going to do with Valeant.” “There are $10 trillion worth of targets,” said Ackman, referring to the combined market cap of the pharmaceutical industry. “I call this the shopping list.” [NYP]

1249256 Responseshttp%3A%2F%2Fdealbreaker.com%2F2014%2F04%2Fbill-ackmans-got-a-fever-and-the-only-prescription-is-more-takeovers%2FBill+Ackman%27s+Got+A+Fever+And+The+Only+Prescription+Is+More+Takeovers2014-04-23+21%3A02%3A43Bess+Levinhttp%3A%2F%2Fdealbreaker.com%2F%3Fp%3D124925 to “Bill Ackman’s Got A Fever And The Only Prescription Is More Takeovers”

"As a leader in the medical aesthetics industry, Allergan is committed to providing the highest quality education to women considering breast aesthetic surgery so that she, along with her surgeon, can make an informed and educated decision about what is right for her. Looking ahead, we will continue to lead the science-based innovation in the area of breast aesthetics by offering women and their surgeons more options with additions to our extensive collection of high-quality breast implant devices."http://www.allergan.com/products/medical_aestheti…

The more frequently you monitor your portfolio, the more likely you are to observe a loss. This is likely to cause short-sighted decisions and could hurt your investment performance. If you are checking your portfolio more than once per quarter, you’re doing it too much.